儿童心肌炎的磁共振成像:趋势及其与费用和结局的关联
基于美国47家医院2004至2019年4195例21岁以下心肌炎住院患儿的回顾性队列显示,心脏磁共振使用率从2%升至37%(OR 1.19,95%CI 1.17-1.21),倾向匹配后磁共振使用与更高中位费用(+5340美元,95%CI +1739至+9936美元)相关、中位住院时间相似,但第90百分位费用更低(-77200美元,95%CI -127373至-31339美元),且更多患儿在入院30天内存活出院(OR 1.89,95%CI 1.28-2.29)。
要点
- 儿童心肌炎住院期间心脏磁共振使用率从2004年2%升至2019年37%(OR 1.19,95%CI 1.17-1.21)。
- 倾向匹配后磁共振使用与更高中位费用相关(+5340美元,95%CI +1739至+9936美元),中位住院时间相似。
- 分位数回归显示磁共振使用与更低第90百分位费用相关(-77200美元,95%CI -127373至-31339美元)。
核心结论
- 过去15年儿童心肌炎心脏磁共振使用增加,与更高住院费用及多数患儿相似的住院时间相关,但在病情最重患儿中费用更低,特定患者使用可能以更低费用改善临床结局。
研究设计与样本
- 回顾性队列研究,纳入2004至2019年报告至儿科健康信息系统的全部21岁以下心肌炎住院患儿,共4195例来自47家医院,中位年龄11.5岁(IQR 1.5-16.0岁),男性2617例(62%)。
诊断标准与关键数值
- 心脏磁共振在成人及儿童心肌炎中具有高敏感度和特异度。
- 磁共振使用率从2004年2%升至2019年37%(OR 1.19,95%CI 1.17-1.21)。
- 倾向匹配后磁共振使用与中位费用增加5340美元相关(95%CI +1739至+9936美元),中位住院时间差异0天(95%CI -1至+1天)。
- 分位数回归显示磁共振使用与第90百分位费用降低77200美元相关(95%CI -127373至-31339美元)。
- 接受磁共振的患儿更多在入院30天内存活出院(OR 1.89,95%CI 1.28-2.29)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac magnetic resonance (CMR) provides tissue characterization and structural and functional data. CMR has high sensitivity and specificity for myocarditis in adults and children. The relationship between pediatric CMR use, cost, and clinical outcome has not been studied.
OBJECTIVES: This work aims to describe temporal trends in CMR imaging for pediatric myocarditis and examine associations between CMR use, hospital cost, and outcomes.
METHODS: A retrospective cohort study of all inpatients <21 years of age with a diagnosis of myocarditis reported to the Pediatric Health Information System (2004-2019) was performed. Trends in CMR use were examined. A propensity-matched subcohort using center and patient level variables was used to assess whether outcomes differed by CMR use.
RESULTS: A total of 4,195 children with myocarditis from 47 hospitals were identified. The median age was 11.5 years (IQR: 1.5-16.0 years) and 2,617 (62%) were male. CMR was used in 23% and mortality occurred in 6%. CMR use during hospitalization increased from 2% in 2004 to 37% in 2019 (odds ratio [OR]: 1.19 [95% CI: 1.17-1.21]). After propensity score matching, CMR use was associated with higher median cost (+$5,340 [95% CI: +$1,739 to +$9,936]) and similar median length of stay (0 days [95% CI: -1 to +1 days]). Using quantile regression, CMR was associated with lower 90th percentile cost (-$77,200 [95% CI: -$127,373 to -$31,339]). More children receiving CMR were discharged alive in the first 30 days after admission (OR: 1.89 days [95% CI: 1.28-2.29]). Within the propensity matched cohort, <10 of 790 CMR recipients died compared to 42 of 790 in the non-CMR group.
CONCLUSIONS: CMR use in children with myocarditis has increased over the past 15 years. CMR use is associated with higher cost of hospitalization and similar length of stay for most children but lower cost among the sickest children. CMR use in specific patients may improve clinical outcomes at a lower cost.
引用
- O'Halloran, Robinson, Watanabe, et al. Magnetic Resonance Imaging in Pediatric Myocarditis: Trends and Associations With Cost and Outcome. JACC Cardiovasc Imaging. 2022. PMID: 35798399. doi:10.1016/j.jcmg.2022.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。